# Gestational Diabetes: The Glucose Test, Diet and Glucose Targets

> An OB-GYN-reviewed guide to how GDM is screened and diagnosed, what the one-step versus two-step glucose tests measure, how diet and lifestyle are the proven first line, and what the Dexcom G7 and ADA targets mean for your daily monitoring.

*Published 2026-06-25 · By Priya Nair, MD*

The short answer
Gestational diabetes is screened at 24–28 weeks using a two-step glucose test; diagnosis requires two abnormal values on the fasting three-hour test. Diet — specifically low-GI, whole-food eating — is the proven first-line intervention, and pregnancy-specific glucose targets are narrower than you might expect: fasting under 95 mg/dL, one-hour post-meal under 140 mg/dL.

Gestational diabetes mellitus (GDM) is a form of glucose intolerance that first appears during pregnancy, and it is far more common than most people realize. Prevalence has risen **36% between 2016 and 2024** in the United States, increasing from 6.0% of deliveries to 8.3% — a nearly unbroken 15-year upward trend driven by advancing maternal age and rising rates of pre-pregnancy obesity, according to research from Northwestern University published in *JAMA Internal Medicine*. Understanding how screening works, what your numbers mean, and which dietary strategies have the strongest evidence puts you in the best position to protect your health and your baby's.

*This article provides general educational information and is not a substitute for personalized medical advice. Talk with your obstetric or diabetes care provider about any screening, monitoring, or treatment decisions specific to your pregnancy.*

## How Does the Gestational Diabetes Screening Process Work?

Universal screening is recommended between **24 and 28 weeks of gestation** for all pregnant women without pre-existing diabetes. The process has two distinct steps, and understanding what each step does — and does not — tell you matters for interpreting results clearly.

### Step One: The 50-Gram Glucose Challenge Test (Non-Fasting)

The first step is a 50-gram oral glucose challenge test (GCT). Unlike many lab draws, **no fasting is required**, which makes it logistically accessible and widely adopted for universal screening. You drink a standardized glucose solution and have venous blood glucose measured exactly one hour later.

According to the [ACOG May 2024 Clinical Practice Update](https://www.endocrinologyadvisor.com/features/gestational-diabetes-screening-guidelines-updated/) in *Obstetrics & Gynecology*, individual practices use cut-off thresholds ranging from **130 to 140 mg/dL** depending on community GDM prevalence and each clinician's preferred balance of test sensitivity and specificity. A value of **200 mg/dL or higher** at the one-hour mark is considered diagnostic for GDM outright — no further testing is needed. Approximately 15–20% of screened women exceed the chosen threshold and proceed to the second step.

### Step Two: The 100-Gram, Three-Hour Diagnostic OGTT (Fasting Required)

The second step is a fasting 100-gram oral glucose tolerance test (OGTT). You fast overnight, have a baseline blood draw, drink the glucose solution, and have blood drawn again at one, two, and three hours. GDM is diagnosed when **two or more of the four values** meet or exceed the Carpenter and Coustan thresholds:

  Carpenter and Coustan Diagnostic Thresholds — Three-Hour 100 g OGTT

      Time Point
      Threshold (mg/dL)
      What It Measures

      Fasting
      ≥ 95
      Baseline glucose after overnight fast

      1 Hour
      ≥ 180
      Acute glucose rise after the load

      2 Hours
      ≥ 155
      How efficiently glucose is clearing

      3 Hours
      ≥ 140
      Near-complete return toward baseline

ACOG prefers the Carpenter and Coustan criteria over older National Diabetes Data Group values because treating women who meet Carpenter-Coustan thresholds has been shown to reduce macrosomia, shoulder dystocia, cesarean delivery, and pregnancy-induced hypertension. Women with only *one* abnormal value do not receive a GDM diagnosis but warrant closer clinical surveillance for the remainder of pregnancy.

One-step alternative:
The American Diabetes Association (ADA) also endorses a one-step approach — a single fasting 75-gram OGTT with values drawn at fasting, one hour, and two hours. The one-step method identifies a substantially higher proportion of women (approximately 11.5% versus 4.9%) because the diagnostic thresholds are different. ACOG's 2024 update continues to support both approaches; your provider will use whichever protocol is standard at their practice.

## What Dietary Strategies Have the Strongest Evidence for GDM?

Diet and lifestyle modification — not insulin or metformin — is the **primary first-line intervention** for GDM, and the evidence base has grown considerably in the past two years.

A landmark 2025 network meta-analysis in *Frontiers in Endocrinology*, covering **28 randomized controlled trials and 2,666 participants**, compared seven distinct dietary patterns head-to-head for glycemic control in GDM. Key findings:

  - **Low-glycemic-index (low-GI) diets** produced the most consistently favorable results across fasting glucose, two-hour postprandial glucose, and insulin resistance (HOMA-IR), and demonstrated a significant reduction in macrosomia risk (OR = 0.12).

  - **DASH diet** showed the strongest overall reduction in fasting blood glucose (SMD = −2.35), two-hour postprandial glucose (SMD = −1.41), and HOMA-IR (MD = −1.90), and reduced cesarean section risk by 46% (OR = 0.54).

  - **Mediterranean diet** consistently improved maternal anthropometry and glycemic profile.

  - **Low-carbohydrate approaches** showed promise for limiting postprandial spikes and are under active investigation.

Practically, a whole-food, low-glycemic eating pattern for GDM looks like this at most meals:

  - **Non-starchy vegetables** (leafy greens, broccoli, zucchini, peppers, cauliflower) as the foundation of each meal

  - **Adequate protein** from eggs, wild fish, poultry, legumes, and grass-fed meat to blunt postprandial glucose rises

  - **Healthy fats** — avocado, olive oil, nuts, seeds — to slow gastric emptying and moderate the glycemic response

  - Minimized refined grains, white bread, fruit juice, and added sugars

  - **Consistent meal timing** to prevent large excursions between highs and lows

Gentle physical activity is a meaningful adjunct. Evidence supports **post-meal walks of 15–20 minutes** as a simple, well-tolerated strategy for reducing postprandial glucose in women with GDM. Your provider may also refer you to a registered dietitian with GDM experience for individualized carbohydrate targets, particularly if your glucose patterns are variable.

## What Are the Glucose Targets During Pregnancy, and How Is Monitoring Done?

Pregnancy-specific glucose targets are significantly tighter than standard adult ranges. This is because even modestly elevated blood sugar is linked to fetal overgrowth, neonatal complications, and downstream metabolic risk for the child.

### Fingerstick Monitoring Targets

For women using traditional capillary fingerstick glucose meters, the standard pregnancy-specific goals are:

  - Fasting: **95 mg/dL or less**

  - One hour after meals: **140 mg/dL or less**

  - Two hours after meals: **120 mg/dL or less**

### Continuous Glucose Monitor (CGM) Targets

Both the **Dexcom G7** and the **Abbott FreeStyle Libre 3** have received FDA clearance for use in gestational diabetes. The [ADA 2026 Standards of Care](https://diabetesjournals.org/care/article/49/Supplement_1/S321/163918/15-Management-of-Diabetes-in-Pregnancy-Standards) specify pregnancy-specific CGM targets:

  - Mean glucose: **below 110 mg/dL**

  - Time in pregnancy range (TIRp): **at or above 90%** (approximately 63–140 mg/dL)

  - Time above pregnancy range (TARp): **below 10%**

Most CGM apps default to the standard adult range of 70–180 mg/dL, which is too wide for pregnancy. Work with your provider to configure alerts and range settings to the pregnancy-specific window. A 2025 randomized controlled trial in *Diabetes Care* confirmed that real-time CGM improved time in range compared to fingerstick testing alone in GDM — and a 5% decrease in TIRp during the second or third trimester is independently associated with increased rates of large-for-gestational-age birth, neonatal hypoglycemia, and NICU admission.

Self-pay cost for CGM sensors runs approximately $185 per month at major pharmacies using discount programs such as GoodRx. Insurance coverage is expanding but remains inconsistent — ask your provider or pharmacist about prior authorization and any CGM benefit your plan may carry.

### When Medication Becomes Necessary

When diet, consistent meal timing, and physical activity are not sufficient to achieve these targets, **insulin is the preferred pharmacologic agent** per ADA 2026 guidance. Insulin does not cross the placenta in clinically meaningful amounts and carries the longest safety record in pregnancy. Metformin and glyburide both cross the placenta and should not be used as first-line agents under current ADA 2026 standards. The goal of optimizing diet and lifestyle first is not to avoid medication when it is genuinely needed — it is to use the most effective root-cause strategy before adding pharmacological support. Your obstetric and diabetes care team will make that decision with you based on your individual glucose patterns.

After delivery, most women's blood glucose returns to normal, but the postpartum window is a critical prevention opportunity. ACOG and the ADA recommend a fasting glucose or 75-gram OGTT at **4–12 weeks postpartum**, with annual monitoring thereafter. Up to 70% of women with GDM develop type 2 diabetes within five to ten years of their pregnancy, with risk highest in the first five years — making postpartum follow-through one of the highest-yield health actions you can take.

## Sources

1. [Gestational Diabetes](https://www.ncbi.nlm.nih.gov/books/NBK545196/)
2. [Gestational Diabetes Screening Guidelines Updated by the ACOG](https://www.endocrinologyadvisor.com/features/gestational-diabetes-screening-guidelines-updated/)
3. [Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026](https://diabetesjournals.org/care/article/49/Supplement_1/S321/163918/15-Management-of-Diabetes-in-Pregnancy-Standards)
4. [Comparative efficacy of dietary interventions for glycemic control and pregnancy outcomes in gestational diabetes: a network meta-analysis of randomized controlled trials](https://pmc.ncbi.nlm.nih.gov/articles/PMC12127149/)
5. [Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial](https://diabetesjournals.org/care/article/48/9/1581/163057/Real-Time-Continuous-Glucose-Monitoring-in)
6. [CGM to Manage Diabetes During Pregnancy — Dexcom G7](https://www.dexcom.com/en-us/g7-cgm-system/gestational)
7. [Gestational Diabetes in US Surges by 36 Percent Over Last Decade](https://www.sciencealert.com/gestational-diabetes-in-us-surges-by-36-percent-over-last-decade)
8. [QuickStats: Percentage of Mothers with Gestational Diabetes, by Maternal Age — National Vital Statistics System, United States, 2016 and 2021](https://www.cdc.gov/mmwr/volumes/72/wr/mm7201a4.htm)
9. [Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis](https://pmc.ncbi.nlm.nih.gov/articles/PMC10941381/)
10. [First trimester urine glyphosate concentrations and gestational diabetes in nulliparas: a nested case-control study](https://link.springer.com/article/10.1186/s12940-025-01183-6)

---
Source: https://natalnew.com/prenatal-care/gestational-diabetes-test-and-diet
Index: https://natalnew.com/llms.txt · Full text: https://natalnew.com/llms-full.txt